Filter registries KELA purch., KELA reimb.
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
SSRI
Extra metadata
List of similar endpoints to
Selective serotonin reuptake inhibitors
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 51973 | 35077 | 16896 |
| Unadjusted prevalence (%) | 19.99 | 23.87 | 14.94 |
| Mean age at first event (years) | 42.96 | 41.70 | 45.58 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.03 | 2.31 [2.08, 2.57] | 1.2e-53 | 3972 |
| 15 years | 0.02 | 2.73 [2.48, 3.00] | 4.8e-98 | 3182 |
| 5 years | 0.00 | 3.75 [3.40, 4.14] | <1e-100 | 1198 |
| 1 year | 0.00 | 2.82 [2.34, 3.40] | 2.8e-27 | 177 |
Index endpoint: SSRI – Selective serotonin reuptake inhibitors
GWS hits:
before Selective serotonin reuptake inhibitors
after Selective serotonin reuptake inhibitors
Loading survival analyses plot
Loading survival analyses table